Search

everythinglearnresearchcommunity

for

Search:↓

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Onion extracts can promote hair growth, but quercetin is not responsible.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

The model helps understand scar contraction and develop new treatments.

Low selenium levels can extend lifespan but worsen health issues.

VDR regulation varies by tissue and is crucial for its biological functions.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Pvalb8 is essential for zebrafish hearing and hair cell development, and its mutation causes hearing loss.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.